Innoviva, Inc.

CIK 1080014 · last filed 2023-01-12

Innoviva, Inc. is a corporate insider who has filed 9 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing, for ARMP, was dated Jan 12, 2023. Across all open-market trades the lifetime net is +$199.1M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $116.9M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$116.86M

Companies

2

Total Filings

9

Lifetime Open-Market Net

$199.13M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ARMP Director 25,076,769 $4.66 $116.86M $140.01M 5 2023-01-12
Entasis Therapeutics Holdings Inc. (ETTX) Delisted 10%+ Owner 28,672,897 $2.19 $62.79M $59.12M 4 2022-02-23

Recent Filings

9 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-01-12 ARMP Buy (P) $0 EDGAR
2022-04-01 ARMP Buy (P) +10,770,416 $53.85M EDGAR
2022-02-23 Entasis Therapeutics Holdings Inc. (ETTX) Delisted Other (J) $0 EDGAR
2022-02-11 ARMP Buy (P) +7,229,584 $36.15M EDGAR
2021-05-20 Entasis Therapeutics Holdings Inc. (ETTX) Delisted Buy (P) +7,462,050 $14.92M EDGAR
2021-03-17 ARMP Buy (P) +8,571,870 $27.86M EDGAR
2020-09-01 Entasis Therapeutics Holdings Inc. (ETTX) Delisted Buy (P) +4,672,897 $12.50M EDGAR
2020-06-12 Entasis Therapeutics Holdings Inc. (ETTX) Delisted Buy (P) +12,677,490 $31.69M EDGAR
2020-03-31 ARMP Buy (P) +7,717,661 $22.15M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.